Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi ; 34(4): 432-437, 2022 Aug 17.
Article in Chinese | MEDLINE | ID: mdl-36116938

ABSTRACT

Schistosomiasis-associated pulmonary arterial hypertension (Sch-PAH) is categorized as WHO Group I PAH because its clinical manifestations, laboratory and hemodynamic features share with PAH of other etiologies, such as idiopathic, heritable, HIV and autoimmune disorders. Sch-PAH is usually a life-threatening complication of hepatosplenic schistosomiasis characterized by changes in the vascular wall, remodeling and vasoconstriction with lesions primarily located in the precapillary segments of the pulmonary vasculature, which may result in a marked and sustained increase in pulmonary vascular resistance, right ventricular failure and ultimately death. Although egg deposition into lung and subsequent inflammatory cascades are key factors in the pathogenesis of Sch-PAH, the exact pathogenesis, course of disease and treatment of Sch-PAH remain largely uncertain. This review mainly discusses the pathophysiological and immunological mechanisms of Sch-PAH, so as to provide insights into the clinical diagnosis and treatment of Sch-PAH.


Subject(s)
Hypertension, Pulmonary , Schistosomiasis , Humans , Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/etiology , Lung , Schistosomiasis/complications
2.
Zhonghua Wei Chang Wai Ke Za Zhi ; 23(6): 616-618, 2020 Jun 25.
Article in Chinese | MEDLINE | ID: mdl-32521987

ABSTRACT

In hospitals and medical schools as densely populated sites with high risk of coronavirus disease 2019 (COVID-19), it is vital to adjust the teaching and training strategy for medical students to ensure curriculum completion with safety. This article aims to introduce the experience of teaching and training for medical students under the epidemic situation at Department of Surgery, Shanghai Medical College, Fudan University and Zhongshan Hospital. The content includes exploring diversified online teaching models for undergraduate surgery courses and clinical practice, carrying out online graduate education and dissertation plans, and strengthening comprehensive education of medical humanity combined with knowledge of COVID-19 prevention. Through implementation of the above teaching strategies, scheduled learning plans of medical students can be well completed in an orderly, safe and quality-ensured manner. Our experience provides practical solution of medical teaching and could be advisable for other medical colleges and teaching hospitals.


Subject(s)
Coronavirus Infections/epidemiology , Digestive System Surgical Procedures/education , Education, Distance/standards , Education, Medical, Undergraduate/standards , Pandemics , Pneumonia, Viral/epidemiology , Specialties, Surgical/standards , Betacoronavirus , COVID-19 , China/epidemiology , Coronavirus Infections/prevention & control , Digestive System Surgical Procedures/standards , Humans , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , SARS-CoV-2
3.
Article in Chinese | MEDLINE | ID: mdl-31446712

ABSTRACT

Summary To study the clinical features, diagnosis and treatments of tuberculous otomastoiditis. One case is reported and literatures are reviewed. In this report, the specimen of the middle ear revealed the presence of acid fast bacilli(AFB), grew mycobacterium tuberculosis on a culture. Lung CT scans demonstrated tuberculosis. After anti-tuberculosis therapy, the symptoms disappeared and did not recur in 3 years. Hydrotympanum can be the early symptom of tuberculous otomastoiditis. When persistent otorrhea can not be improved by conventional therapy, tuberculous otomastoiditis should be considered as one of the differential diagnosis.


Subject(s)
Mastoiditis/diagnosis , Otitis Media with Effusion/etiology , Tuberculosis/diagnosis , Ear, Middle/microbiology , Ear, Middle/pathology , Humans , Mycobacterium tuberculosis/isolation & purification , Tomography, X-Ray Computed
4.
IEEE Trans Med Imaging ; 38(9): 2104-2113, 2019 09.
Article in English | MEDLINE | ID: mdl-30703015

ABSTRACT

Electrical impedance tomography (EIT) is considered as a potential candidate for brain stroke imaging due to its compactness and potential use in bedside and emergency settings. The electrode-skin contact impedance and low conductivity of skull pose some practical challenges to the EIT head imaging. This paper studies the application of capacitively coupled electrical impedance tomography (CCEIT) in brain imaging for the first time. CCEIT is a new contactless EIT technique which uses voltage excitation without direct contact with the skin, as oppose to directly injecting the current to the skin in EIT. Because the safety issue of a new technique should be strictly treated, simulation work based on a simplified head model was carried out to investigate the safety aspects of CCEIT. By comparing with the standard EIT excited by a typical safe current level used in brain imaging, the safe excitation reference of CCEIT is obtained. This is done by comparing the maximum level of internal electrical field (internal current density) of EIT and that of CCEIT. Simulation results provide useful knowledge of excitation signal level of CCEIT and also show a critical comparison with traditional EIT. Practical experiments were carried out with a 12-electrode CCEIT phantom, saline, and carrot samples. Experimental results show the feasibility and potential of CCEIT for stroke imaging. In this paper, the anomaly diameter resolution is 10 mm (1/18 of the phantom diameter), which indicates that small-volume stroke could be detected. This is achieved by a low excitation voltage of 1 V, showing the possibility of even better performance when higher but yet safe level of excitation voltages is used.


Subject(s)
Brain/diagnostic imaging , Electric Impedance , Tomography/methods , Computer Simulation , Electric Conductivity , Humans , Models, Biological , Phantoms, Imaging , Stroke/diagnostic imaging
5.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi ; 30(15): 1215-1218, 2016 Aug 05.
Article in Chinese | MEDLINE | ID: mdl-29798332

ABSTRACT

Objective:The aim of this study is to investigate the inhibition of nasopharyngeal carcinoma cells by indole-3-carbinol in vitro and in vivo.Method:The human nasopharyngeal carcinoma cell line CNE2 was treated in different concentrations 0,100,200,300 µmol/L of indole-3-carbinol. Then we detected cell proliferation after 0,24,48 and 72 h, apoptosis after 48 h and the levels of PI3K/Akt pathway-related proteins in vitro. The BALB/c nude mice were divided into three groups: prevention group, treatment group and control group. In vivo, the nude mice in every group were inoculated with nasopharyngeal carcinoma cells CNE2, and mice in prevention and treatment groups were given feed containing 0.5% indole-3-carbinol. We investigated the tumoricidal effect of I3C in nude mice , and eight weeks later, the PI3K/Akt pathway-related proteins expressions in tumors from nude mice of each group were detected.Result:With the indole-3-carbinol concentration increased, cell proliferation decreased and apoptosis increased significantly.The levels of PI3K/Akt pathway-related proteins were decreased.In animal experiments, the prevention and treatment group developed smaller tumors, and the expression of PI3K/Akt pathway-related proteins in prevention and treatment groups PI3K/Akt pathway also reduced, compared to control group. Meanwhile, nearly no changes of heart, liver and kidney tissues in all groups were seen in HE staining.Conclusion:Indole-3-carbinol inhibited the growth of nasopharyngeal carcinoma cells and induced apoptosis effectively in vivo and in vitro. The mechanism might be that indole-3-carbinol could suppress PI3K/Akt pathway.


Subject(s)
Apoptosis/drug effects , Carcinoma/drug therapy , Cell Proliferation/drug effects , Indoles/pharmacology , Nasopharyngeal Neoplasms/drug therapy , Animals , Cell Line, Tumor , Humans , Mice , Mice, Inbred BALB C , Mice, Nude , Nasopharyngeal Carcinoma , Phosphatidylinositol 3-Kinases , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction/drug effects
6.
Genet Mol Res ; 14(4): 19191-202, 2015 Dec 29.
Article in English | MEDLINE | ID: mdl-26782572

ABSTRACT

Genetic polymorphisms (C677T and A1298C) in methylenetetrahydrofolate reductase (MTHFR) were shown to be related to prostate cancer risk in previous studies; however, the results are controversial. We performed a meta-analysis of previous studies and quantitatively estimated these associations. Pubmed, Embase, and Cochrane Library Database were searched for published case-control studies evaluating the association between C677T (or A1298C) and prostate cancer risk. Pooled associations were presented as odds ratios (ORs) along with their 95% confidence intervals. Twenty-one case control studies were identified for meta-analysis that included 21,581 participants. No significant associations were found between the MTHFR polymorphisms C677T or A1298C and prostate cancer risk in our meta-analysis. However, in subgroup analyses, the C677T CT polymorphism was associated with increased prostate cancer risk in East Asians (CT vs CC+TT: OR = 1.324, P = 0.03). The A1298C CC polymorphism in MTHFR was also linked to slightly reduced prostate cancer risk in European residents (CC vs AC+AA: OR = 0.751, P = 0.004; CC vs AA: OR = 0.768, P = 0.011), whereas it was associated with a significantly increased prostate cancer risk in Asian residents (CC vs AA: OR = 1.862, P = 0.006). The C677T CT polymorphism of MTHFR may be a risk factor for prostate cancer in East Asians. The association between the MTHFR A1298C CC genotype and prostate cancer risk may vary within different populations. Large-scale well-designed studies are required to confirm these associations.


Subject(s)
Genetic Predisposition to Disease , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Polymorphism, Single Nucleotide , Prostatic Neoplasms/genetics , Alleles , Asian People , Case-Control Studies , Gene Expression , Gene Frequency , Humans , Male , Odds Ratio , Prostate/metabolism , Prostate/pathology , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/ethnology , Prostatic Neoplasms/pathology , Risk Factors , White People
7.
Genet Mol Res ; 13(2): 3787-99, 2014 May 16.
Article in English | MEDLINE | ID: mdl-24938465

ABSTRACT

Homocysteine (Hcy) is an independent risk factor of atherosclerosis through its involvement with the methionine cycle. In this study, we aimed to determine the blood vessel global methylation rate in Hcy-induced atherosclerosis in apolipoprotein-E-deficient (ApoE-/-) mice, and to explore the possible mechanism of this change in endothelial cells. ApoE-/- mice were divided into a hyperlipidemia (HLP) group, a hyperhomocysteinemia (HHcy) group, and an HHcy + folate + vitamin B12 (HHcy+FA+VB) group. Wild-type C57BL/6J mice were prepared as controls. Total Hcy, lipids, S-adenosylmethionine (SAM), and S-adenosylhomocysteine (SAH) contents in serum were measured with an automatic biochemistry analyzer and high-performance liquid chromatography. Methylation of B1 repetitive elements in blood vessels was tested using nested methylation-specific-polymerase chain reaction (nMS-PCR). Endothelial cells (ECs) were pretreated with Hcy or by adding FA and VB. Lectin-like oxidized LDL receptor-1 (LOX-1) expressions were determined by quantitative PCR, Western blot, and nMS-PCR. The HHcy group displayed severe HLP and HHcy. SAM and SAH contents were also elevated in the HHcy group compared with other groups. Methylation of B1 repetitive elements was significantly increased in the HHcy group (0.5050 ± 0.0182) compared to the HLP (0.5158 ± 0.0163) and control (0.5589 ± 0.0236) groups. mRNA and protein expressions of LOX-1 increased (0.2877 ± 0.0341, 0.6090 ± 0.0547), whereas methylation expression decreased (0.5527 ± 0.0148) after 100 µM Hcy stimulation in ECs. In conclusion, Hcy-induced atherosclerosis was closely associated with induced hypomethylation status in the blood vessel, and this process was partially mediated by LOX-1 DNA methylation.


Subject(s)
Atherosclerosis/genetics , Blood Vessels/metabolism , DNA Methylation/genetics , Scavenger Receptors, Class E/genetics , Animals , Apolipoproteins E/genetics , Atherosclerosis/chemically induced , Atherosclerosis/pathology , Blood Vessels/drug effects , Homocysteine/toxicity , Humans , Hyperhomocysteinemia/chemically induced , Hyperhomocysteinemia/genetics , Hyperhomocysteinemia/pathology , Hyperlipidemias/chemically induced , Hyperlipidemias/genetics , Hyperlipidemias/pathology , Lipids/blood , Mice , Scavenger Receptors, Class E/metabolism
8.
Diabet Med ; 27(6): 636-43, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20546280

ABSTRACT

AIM: To evaluate annual prevalence and incidence of Type 2 diabetes and to examine possible trends among adults in Taiwan. METHODS: A retrospective nationwide longitudinal study using the Taiwan National Health Insurance Research Database collected during 1999-2004. Adult patients aged > or = 20 years old with prevalent and incident Type 2 diabetes were identified using ICD-9-CM diagnostic codes. Age-specific and age-direct-standardized annual incidence and prevalence were calculated to describe their trends in different gender and age group and compared using Poisson regression. RESULTS: During the study years, the age-standardized prevalence of Type 2 diabetes increased from 4.7 to 6.5% for men and from 5.3 to 6.6% for women. The increasing trends in prevalence were significant and higher among people aged < 40 and > or = 80 years. The age-standardized incidence rates of Type 2 diabetes per 1000 person-years were approximately 7.6 and remain stable for men, but decreasing from 7.7 to 6.9 for women. However, the incidence increased significantly in younger adults aged < 40 years whose relative incidence (RI with 95% confidence interval) was 1.31 (1.20-1.42) for men and 1.04 (1.01-1.08) for women. The incidence trends for people aged > or = 40 years were decreased for men and women. The differences in incidence trends between age groups and between genders were all statistically significant (all P < 0.001). CONCLUSIONS: This study demonstrated a substantial increasing trend in Type 2 diabetes prevalence during 1999-2004 among adults in Taiwan. Despite the incidence decreased in older people, young men aged 20-40 years were most susceptible to higher incidence of Type 2 diabetes.


Subject(s)
Databases, Factual , Diabetes Mellitus, Type 2/epidemiology , Adult , Age Factors , Aged , Aged, 80 and over , Female , Humans , Incidence , Male , Middle Aged , National Health Programs , Prevalence , Retrospective Studies , Statistics as Topic , Taiwan/epidemiology , Young Adult
9.
Nanotechnology ; 19(8): 085706, 2008 Feb 27.
Article in English | MEDLINE | ID: mdl-21730737

ABSTRACT

The influence of structure variation on the 1/f noise of nanometric boron doped hydrogenated polymorphous silicon (pm-Si:H) films was investigated. The films were grown by the conventional radio frequency plasma enhanced chemical vapor deposition (PECVD) method. Raman spectroscopy was used to reveal the crystalline volume fraction (X(c)) and crystal size of the pm-Si:H. The measurement of optical and structure properties was carried out with spectroscopic ellipsometry (SE) in the Tauc-Lorentz model. A Fourier transform infrared (FTIR) spectrometer was used to characterize the presence of nanostructure-sized silicon clusters in pm-Si:H film deposited on KBr substrate. The electrical properties of the films were measured using evaporated coplanar nickel as the electrode. A semiconductor system was designed to obtain the 1/f noise of pm-Si:H film as well as that of amorphous and microcrystalline silicon films. The results demonstrate that the 1/f noise of pm-Si:H is nearly as low as that of microcrystalline silicon and much lower than that of amorphous silicon. The disorder to order transition mechanism of crystallization was used to analyze the decrease of noise compared with amorphous silicon.

10.
J Colloid Interface Sci ; 302(2): 613-9, 2006 Oct 15.
Article in English | MEDLINE | ID: mdl-16890950

ABSTRACT

In this work, we used different treatment methods (ultrasonic degreasing, hydrochloric acid treatment, and oxygen plasma) to modify the surfaces of indium-tin oxide (ITO) substrates for organic light-emitting devices. The surface properties of treated ITO substrates were studied by atomic force microscopy (AFM), X-ray photoelectron spectroscopy (XPS), sheet resistance, contact angle, and surface energy measurements. Experimental results show that the ITO surface properties are closely related to the treatment methods, and the oxygen plasma is more efficient than the other treatments since it brings about smoother surfaces, lower sheet resistance, higher work function, and higher surface energy and polarity of the ITO substrate. Moreover, polymer light-emitting electrochemical cells (PLECs) with differently treated ITO substrates as device electrodes were fabricated and characterized. It is found that surface treatments of ITO substrates have a certain degree of influence upon the injection current, brightness, and efficiency, but hardly upon the turn-on voltages of current injection and light emission, which are in agreement with the measured optical energy gap of the electroluminescent polymer. The oxygen plasma treatment on the ITO substrate yields the best performance of PLECs, due to the improvement of interface formation and electrical contact of the ITO substrate with the polymer blend in the PLECs.


Subject(s)
Indium , Light , Luminescent Agents/chemical synthesis , Polymers , Tin Compounds , Indium/chemistry , Indium/radiation effects , Luminescence , Luminescent Agents/chemistry , Microscopy, Atomic Force/methods , Polymers/chemistry , Polymers/radiation effects , Sensitivity and Specificity , Spectrophotometry/methods , Surface Properties , Tin Compounds/chemistry , Tin Compounds/radiation effects , X-Rays
11.
Diabetes Obes Metab ; 8(2): 184-91, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16448522

ABSTRACT

BACKGROUND AND AIM: Gliclazide-modified release (gliclazide MR) is a new formulation of the sulfonylurea gliclazide designed for once-daily administration. The hydrophilic matrix of hypromellose-based polymer in the new formulation induces a progressive drug release, which parallels the 24-h glycaemic profile in type 2 diabetic patients. The aim of this study was to compare the efficacy and safety of gliclazide MR (once-daily administration) versus gliclazide (twice-daily administration) in Chinese type 2 diabetic patients. MATERIALS AND METHODS: Sixty-three type 2 diabetic Chinese patients who had been on diet control alone or on treatment with metformin or on low dose of sulfonylurea were randomized to either gliclazide MR taken once daily or gliclazide taken twice daily. Dosage of metformin was maintained throughout the study, and the sulfonylurea was stopped. The dose of gliclazide MR was increased at 1-month intervals from 30 mg to 120 mg, while that of gliclazide from 80 mg to 320 mg until metabolic control was achieved [fasting plasma glucose (FPG) < or = 7.7 mmol/l] or the maximum dose reached. Efficacy was mainly evaluated by levels of haemoglobin A1c (HbA1c) and FPG. RESULTS: The mean baseline characteristics of the full analysis set 1 (FAS1) (HbA1c, n = 58) and the FAS2 (FPG, n = 61) were comparable in both groups. The levels of HbA1c decreased similarly in both groups over the treatment period: -1.6 +/- 1.6% (p < 0.001) on gliclazide MR (n = 31) and -1.6 +/- 1.4% (p < 0.001) on gliclazide (n = 27). Decrease in HbA1c was observed irrespective of pre-existing therapy for diabetes: -2.3 +/- 1.5% for patients on diet alone; -0.6 +/- 1.3% for patients switched from sulfonylurea to study drug and -1.4 +/- 0.8% for patients on metformin in combination with study drug. FPG decreased significantly from 177.5 +/- 63.5 to 136.7 +/- 42.2 (p < 0.001, n = 32) on gliclazide MR and not significant from 188.2 +/- 62.6 to 163.7 +/- 67.9 (p = 0.059, n = 29) on gliclazide. Both treatments were very well tolerated with no major hypoglycaemic episodes requiring external assistance; only three patients experienced mild hypoglycaemic episodes. CONCLUSIONS: Once-daily gliclazide MR showed a better trend in improving blood glucose control in comparison with gliclazide in type 2 diabetic Chinese patients irrespective of the pre-existing anti-diabetic treatment. The safety profiles of gliclazide MR and gliclazide were similar with a small number of patients having reported hypoglycaemic episodes. Once-daily dosing with gliclazide MR should improve patient compliance, an important factor in long-term glycaemic control.


Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Gliclazide/administration & dosage , Hypoglycemic Agents/administration & dosage , Adult , Aged , Asian People/ethnology , Blood Glucose/metabolism , Delayed-Action Preparations , Diabetes Mellitus, Type 2/ethnology , Double-Blind Method , Fasting/blood , Female , Glycated Hemoglobin/metabolism , Humans , Male , Middle Aged
12.
Diabet Med ; 22(12): 1690-5, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16401313

ABSTRACT

AIM: Apolipoprotein AV (APOA5) is an important determinant of plasma triglyceride concentration. This study aimed to investigate the relationship of an amino acid substitution at position 182 (G182C) of the apolipoprotein AV (APOA5) gene with triglyceride concentration in a Taiwanese population. METHODS: This study enrolled two cohorts: non-diabetic subjects (112 males and 89 females) aged 50.3+/-11.0 years (mean+/-sd) and diabetic subjects (106 males and 96 females) aged 62.1+/-10.3 years. The relationship between the G182C polymorphism (rs 2075291) and plasma triglycerides was examined. Demographic and metabolic parameters including age, sex, body mass index, fasting plasma glucose and total cholesterol were also obtained. RESULTS: The G182C polymorphism was a determinant of plasma triglycerides in both non-diabetic (P=0.022) and diabetic (P=0.003) groups, independent of age, gender, fasting plasma glucose, body mass index and total cholesterol. In the diabetic group, this genetic polymorphism interacts significantly (P=0.032) with fasting plasma glucose concentration on plasma triglycerides after adjustment for age, sex, body mass index and total cholesterol. CONCLUSIONS: In conclusion, the G182C polymorphism of the APOA5 gene affects plasma triglycerides in both non-diabetic and diabetic populations. The observed interaction of gene and glycaemic control further indicates a multifactorial nature of clinical phenotypes in subjects with Type 2 diabetes.


Subject(s)
Apolipoproteins/genetics , Diabetes Mellitus, Type 2/genetics , Polymorphism, Single Nucleotide/genetics , Triglycerides/blood , Adult , Aged , Apolipoprotein A-V , Apolipoproteins A , Cohort Studies , Female , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Taiwan
13.
Am J Kidney Dis ; 38(6): 1185-90, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11728949

ABSTRACT

Platelet glycoprotein receptors play a role in the pathogenesis of chronic diabetic complications. Genetic polymorphisms of the alpha2beta1 integrin and glycoprotein IIIa (GPIIIa) have been associated with myocardial infarction, stroke, and diabetic retinopathy. To identify risk factors for their development in a cohort of patients with type 2 diabetes, we evaluated clinical variables and genetic polymorphisms in the alpha2beta1 integrin and GPIIIa genes. Two hundred thirty-four subjects with type 2 diabetes (126 patients with and 108 patients without diabetic nephropathy), as well as 217 nondiabetic healthy subjects, were recruited for this study. Clinical factors for investigation included sex, age at diagnosis, duration of diabetes, body mass index (BMI), and fasting plasma glucose, hemoglobin A(1c) (HbA(1c)), total cholesterol, and triglyceride levels. Genotypes were determined by polymerase chain reaction and restriction fragment length polymorphism analyses. No difference in the Bgl II polymorphism of the alpha2beta1 integrin gene was found between patients with type 2 diabetes with or without nephropathy (11 [8.7%], 47 [37.3%], and 68 patients [54.0%] versus 10 [9.3%], 32 [29.6%], and 66 patients [61.1%] for Bgl II+/+, Bgl II+/-, and Bgl II-/-, respectively; P = 0.271). Multiple logistic regression analyses showed that duration of diabetes, BMI, hypertension, and poor glycemic control were four independent predictors for the development of diabetic nephropathy. No contribution of the Bgl II+ allele of the alpha2beta1 integrin was found for the risk for nephropathy (odds ratio, 1.258; 95% confidence interval, 0.655 to 2.418; P = 0.490). The Pl(A2) allele genotype was not found among our studied subjects. In conclusion, age, duration of diabetes, BMI, and HbA(1c) level are strong predictors for nephropathy in patients with type 2 diabetes. However, the Bgl II polymorphism of the alpha2beta1 integrin gene and the Apa I polymorphism of the platelet GPIIIa gene do not have a major role in the development of diabetic nephropathy in our population.


Subject(s)
Blood Platelets/metabolism , Collagen/genetics , Diabetes Mellitus, Type 2/physiopathology , Diabetic Nephropathies/physiopathology , Platelet Glycoprotein GPIIb-IIIa Complex/genetics , Collagen Type I , Female , Humans , Logistic Models , Male , Middle Aged , Odds Ratio , Polymorphism, Genetic
14.
Life Sci ; 69(19): 2265-77, 2001 Sep 28.
Article in English | MEDLINE | ID: mdl-11669469

ABSTRACT

The neuroprotective properties of topiramate were evaluated in a rat model of stroke in which neurodegeneration was induced by temporary global ischemia. In this model, the ischemia resulted from 11 min of cardiac arrest during atraumatic chest compression. Resuscitated rats exhibit a characteristic neurological syndrome characterized by sound-induced convulsions, specific motor and behavioral deficits, and death of hippocampal CA1 pyramidal neurons. Topiramate, when administered i.v. 30 min after resuscitation, reduced the degree of motor impairment (P< 0.05 vs control at doses of 10 and 20 mg/kg) and seizure severity (P< 0.05 vs control at a dose of 10 mg/kg on the fifth recovery day). The highest dose of topiramate (20 mg/kg i.v.) eliminated nearly all histologic signs of hippocampal ischemic neuronal injury (P< 0.001). Phenytoin at 20 mg/kg i.v. exhibited neuroprotectant effects similar to those observed for topiramate at 20 mg/kg i.v.. In normal rats, neither topiramate nor phenytoin at 20 mg/kg i.v. induced any apparent neurological impairment; however, at 40 and 60 mg/kg i.v. both induced a mild impairment typical of most anticonvulsants. The results of this study support the concept that topiramate possesses neuroprotective properties.


Subject(s)
Fructose/analogs & derivatives , Fructose/pharmacology , Neurodegenerative Diseases/prevention & control , Neuroprotective Agents/pharmacology , Animals , Disease Models, Animal , Fructose/therapeutic use , Ischemia/complications , Male , Neurodegenerative Diseases/etiology , Neuroprotective Agents/therapeutic use , Rats , Rats, Long-Evans , Topiramate
15.
J Endocrinol Invest ; 23(3): 163-9, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10803473

ABSTRACT

ACTH stimulation is useful in assessing the hypothalamo-pituitary-adrenal axis. However, there is still some debate about the proper dose and interpretation. We designed a new protocol using repetitive graded ACTH stimulation. Thirty-two patients with the diagnosis of adrenal insufficiency (Al) were studied. After taking samples for baseline ACTH and cortisol, 1 microg fresh-prepared ACTH (Synacthen (1-24)) was injected intravenously, then 5, 50 and 100 microg at hourly interval. Cortisol responses were measured at 30, 60, 120, 180 and 240 min. The secondary Al group (26 subjects) had cortisol responses in between those of the control group (8 subjects) and the primary Al group (6 subjects). The minimal overlap between the secondary Al group and the control group occurred at a 30-min cortisol response after 1 microg ACTH stimulation, using 20 microg/dl as the cut-off level. There was only one exception which showed an episodic release at 30 min. There were 5, 10 and 9 patients with secondary Al who responded normally to 5, 50 and 100 microg ACTH stimulation, respectively. Maximal cortisol increments of the primary Al group were all below 4 microg/dl. Although there were 11 cases of secondary Al whose cortisol responses overlapped with those of primary Al, only two of them had a cortisol increment less than 4 microg/dl. Our new protocol combines the advantage of the low dose ACTH stimulation test, a sensitive method for detecting mild Al, and the ACTH infusion test, a longer test to mimic surgical stress.


Subject(s)
Adrenal Insufficiency/diagnosis , Adrenocorticotropic Hormone , Adrenocorticotropic Hormone/administration & dosage , Adult , Aged , Aged, 80 and over , Dose-Response Relationship, Drug , Female , Humans , Hydrocortisone/blood , Male , Middle Aged
16.
J Neurol ; 246(5): 394-8, 1999 May.
Article in English | MEDLINE | ID: mdl-10399873

ABSTRACT

The goal of this study was to identify risk factors for diabetic peripheral sensory neuropathy in type 2 diabetes mellitus in a Chinese population. Peripheral sensory neuropathy was detected by quantitative sensory testing (5.07/10 g monofilament, neurometer and 128-Hz Riedel Seiffert graduated tuning fork). Those who had two or more abnormal quantitative sensory testings were defined as having diabetic sensory neuropathy. Of the 558 non-insulin dependent diabetes mellitits subjects, 62 (11.1%) had peripheral neuropathy. In 59 (10.6%) detection was by monofilament testing, 45 (8.1%) by graduated tuning fork, and 189 (33.9%) by neurometer. In a multivariate logistic regression model, age and insulin therapy were significantly associated with peripheral neuropathy. Age, serum triglyceride, height, and fasting plasma glucose were independently associated with large fiber neuropathy. Our results confirm the previously identified multiple risk factors of diabetic neuropathy. Different quantitative sensory testings detect different nerve fiber defects. The weak correlation between these tests indicates the need to use more than one test in screening for diabetic neuropathy.


Subject(s)
Diabetic Neuropathies/diagnosis , Sensation Disorders/diagnosis , Sensation/physiology , Aged , Diabetes Mellitus, Type 2 , Diabetic Neuropathies/physiopathology , Female , Humans , Male , Middle Aged , Peripheral Nervous System Diseases/physiopathology , Risk Factors , Sensation Disorders/physiopathology , Vibration
17.
Diabetes Res Clin Pract ; 46(2): 177-82, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10724098

ABSTRACT

A multi-center prospective study was conducted to assess the function and impact of diabetic education programs on diabetic control. A total of 208 subjects with type 2 diabetes were recruited. Diabetes self-care, assessed by questionnaire, was evaluated before, and 4 months after attending a diabetes education course. A total of 121 subjects who received advanced diabetes education courses were designated as the experimental group. A second group of 87 cases receiving a basic course served as controls. In addition to basic knowledge, the advanced education programs included dietary control, blood glucose monitoring, management of hypoglycemia, medication compliance, foot care and exercise. Diabetes self-care techniques were significantly improved in the experimental group. The overall score for diabetes self-care techniques improved in both groups at the 4th month over baseline values. The change was significant with the controls' (P < 0.001). Multiple regression analysis confirmed the intensity of diabetic education was the only significant variable correlated with the decrease of fasting blood glucose and systolic blood pressure. In conclusion, integrated and intensive diabetes education program in diabetes education centers provides an effective method for improving diabetes self-care techniques and metabolic outcome.


Subject(s)
Diabetes Mellitus, Type 2/therapy , Patient Education as Topic , Aged , Blood Glucose/analysis , Blood Pressure , Diabetes Mellitus, Type 2/physiopathology , Fasting/blood , Female , Glycated Hemoglobin/analysis , Humans , Male , Middle Aged , Prospective Studies , Self Care , Surveys and Questionnaires , Systole , Taiwan
18.
J Formos Med Assoc ; 97(8): 521-7, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9747061

ABSTRACT

The purpose of this study was to evaluate the need for an outpatient clinic for screening chronic complications of diabetes mellitus and to explore the major risk factors for such complications. A total of 558 patients (293 men and 265 women, aged 61.4 +/- 10.0 yr) with non-insulin-dependent diabetes mellitus were recruited. All examinations were performed in all patients except for those with previously known complications. A nonmydriatic fundus camera was used to detect retinopathy. Microalbuminuria was detected with a semiquantitative method. A monofilament, semiquantitative tuning fork and neurometer were used to detect peripheral neuropathy. The relationships of demographic and metabolic factors with diabetic complications were analyzed. Among the 558 patients, 443 (79.3%) were found to have at least one chronic complication. Less than half (41.5%) of patients had been identified as having a complication(s) before screening. The rates of undiagnosed complications ranged from 46.7% to 83.4% for each complication. The duration of diabetes, hemoglobin A1c (HbA1c), and systolic blood pressure (BP) were strongly associated with microvascular complications (p = 0.009, 0.018 and 0.037, respectively). The microvascular complication rates reached a plateau when HbA1c reached 8.0% at least among patients with a systolic BP of less than 130 mmHg. Our findings indicate that undiagnosed complications (average, 58.5%) can be found with routine screening, increasing the chances for prompt attention and early intervention. The duration of diabetes, HbA1c, and systolic BP were strongly associated with microvascular complications. Diabetes care can be improved by the implementation of a screening clinic in daily practice. Identification of the specific risk factors in a defined population in specific clinical settings will allow early modification of interventions for optimal diabetes care.


Subject(s)
Diabetes Complications , Managed Care Programs , Adult , Aged , Chronic Disease , Diabetic Angiopathies/etiology , Female , Humans , Male , Middle Aged , Outpatient Clinics, Hospital , Risk Factors
19.
Acta Anaesthesiol Scand ; 41(4): 511-5, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9150781

ABSTRACT

BACKGROUND: Although hypothermia is widely used to protect the brain during cardiac and neurologic surgery, the optimal level of cooling has not been established. This study examined the protective effect of graded levels of surface cooling on cerebral function in rats after complete global cerebral ischemia. METHODS: Groups of ketamine-anesthetized rats (13 animals in each group) were cooled to cranial temperatures of 34, 30, 27, 24, or 22 degrees C before circulatory arrest. Also a normothermic (37 degrees C) group was tested. After cooling, an 11-min circulatory arrest was produced by atraumatic chest compression. Circulatory arrest was followed by cardiopulmonary resuscitation and rewarming without postischemic intensive care. On the fifth postinsult day, neurologic outcome was scored on a 50-point neurodeficit scale (NDS 0 = normal). The percent of ischemic pyramidal neurons in the CA1 hippocampal region was also determined. RESULTS: There were no survivors in the normothermic group. Neurologic recovery was enhanced with 30 degrees C cranial temperature, as compared to outcome in the 34 degrees C group. Further cooling did not change outcome. The neurodeficit scales were significantly lower in all other groups compared to the 34 degrees C group on the fifth postinsult day. The percent of ischemic neurons did not change significantly as a function of cooling, but the lowest count appeared at 27 degrees C. CONCLUSION: In this model, moderate (30 degrees C) cooling improved neurologic outcome. There was no additional benefit from more extreme hypothermia.


Subject(s)
Heart Arrest, Induced , Animals , Brain Ischemia/physiopathology , Male , Rats
20.
Life Sci ; 59(10): PL127-31, 1996.
Article in English | MEDLINE | ID: mdl-8761322

ABSTRACT

Topiramate, a structurally novel anticonvulsant, and phenytoin were evaluated in a rat model of ischemia-induced epilepsy. In this model a transient global cerebral ischemia is induced by cardiac compression. By precisely controlling the experimental conditions the procedure causes reproducible neurological deficits that include audiogenic epileptic seizures. The seizures can be broadly separated into three types reflecting the degree of severity: wild running, clonic seizures, and tonic extension seizures of the forelimbs and hindlimbs. Topiramate and phenytoin blocked all three types of seizures. Calculated ED50 values for topiramate 1 hr after oral administration were 8.2, 13.0 and 36.1 mg/kg for blockade of tonic extension seizures, clonic seizures and wild running, respectively. Corresponding ED50 values for phenytoin were 5.0, 10.8 and 20.7 mg/kg. These results support the concept that the anticonvulsant activity of these drugs is due primarily to an ability to block the spread of seizures.


Subject(s)
Anticonvulsants/pharmacology , Brain Ischemia/complications , Epilepsy/drug therapy , Fructose/analogs & derivatives , Phenytoin/pharmacology , Acoustic Stimulation , Animals , Epilepsy/etiology , Fructose/pharmacology , Male , Rats , Topiramate
SELECTION OF CITATIONS
SEARCH DETAIL
...